Advances in drug development & approvals landscape, and industry partnerships

Authors

  • Vasu Pestonjamasp

DOI:

https://doi.org/10.5912/jcb680

Keywords:

Biotechnology, drug development, biosimilars, approval, partnership

Abstract

The Biotechnology Industry Organization (BIO) held its 2014 Annual Convention at the San Diego Convention Center, CA (June 23-26, 2014). This event was attended by more than 15,660 industry leaders that included 2,500 Chief Executive Officers (CEOs), several U.S. Governors, and ­representatives from 50 states and 70 countries. The BIO Exhibition saw presence of over 1,800 exhibitors with 55 state and international pavilions. Additional features of the Convention comprised 192 company presentations, 800 speakers and 160 sessions in 9 specialty forums and 8 educational tracks and 29,000+ one-on-one partnering meetings between 3,100+ ­companies. Keynote speakers featured Sir Richard Branson and Former Secretary of State Hillary Rodham Clinton. 

Published

2014-09-27

Issue

Section

Conference Report